A covalent PIN1 inhibitor selectively targets cancer cells by a dual mechanism of action

[1]  G. Sal,et al.  PIN1 in breast development and cancer: a clinical perspective , 2016, Cell Death and Differentiation.

[2]  S. Bicciato,et al.  Glucocorticoid receptor signalling activates YAP in breast cancer , 2017, Nature Communications.

[3]  A. Rosato,et al.  Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer , 2016, Nature Cell Biology.

[4]  Xiao Zhen Zhou,et al.  The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target , 2016, Nature Reviews Cancer.

[5]  M. V. Giuli,et al.  Prolyl-isomerase Pin1 controls Notch3 protein expression and regulates T-ALL progression , 2016, Oncogene.

[6]  R. Bristow,et al.  Radiotherapy-induced miR-223 prevents relapse of breast cancer by targeting the EGF pathway , 2016, Oncogene.

[7]  Rachel M. Webster.  Combination therapies in oncology , 2016, Nature Reviews Drug Discovery.

[8]  Jennifer L. Knight,et al.  OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. , 2016, Journal of chemical theory and computation.

[9]  R. Amaravadi,et al.  Emerging strategies to effectively target autophagy in cancer , 2016, Oncogene.

[10]  A. Gautam,et al.  STATE , 2016, Intell. Serv. Robotics.

[11]  S. Hanes.  Prolyl isomerases in gene transcription. , 2015, Biochimica et biophysica acta.

[12]  C. Brandl,et al.  Peroxide-mediated oxidation and inhibition of the peptidyl-prolyl isomerase Pin1. , 2015, Biochimica et biophysica acta.

[13]  Christopher L. Warren,et al.  Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α* , 2015, The Journal of Biological Chemistry.

[14]  P. Pandolfi,et al.  Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer , 2015, Nature Medicine.

[15]  D. Butterfield,et al.  Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease , 2015, Neurobiology of Disease.

[16]  J. Lieberman,et al.  The Rab2A GTPase Promotes Breast Cancer Stem Cells and Tumorigenesis via Erk Signaling Activation , 2015, Cell reports.

[17]  Jing-Zhang Wang,et al.  Pin1-based diagnostic and therapeutic strategies for breast cancer. , 2015, Pharmacological research.

[18]  Yingyan Yu,et al.  Pin1 is Overexpressed and Correlates with Poor Prognosis in Gastric Cancer , 2014, Cell Biochemistry and Biophysics.

[19]  T. Hunter,et al.  Prolyl isomerase Pin1 in cancer , 2014, Cell Research.

[20]  G. Poon,et al.  Prodrug Applications for Targeted Cancer Therapy , 2014, The AAPS Journal.

[21]  J. Lieberman,et al.  Prolyl isomerase Pin1 acts downstream of miR200c to promote cancer stem-like cell traits in breast cancer. , 2014, Cancer research.

[22]  Kai Zhu,et al.  Structure-Based Virtual Screening Approach for Discovery of Covalently Bound Ligands , 2014, J. Chem. Inf. Model..

[23]  D. Rimm,et al.  Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation , 2014, Oncogene.

[24]  A. Krešo,et al.  Evolution of the cancer stem cell model. , 2014, Cell stem cell.

[25]  Matthias Dobbelstein,et al.  Targeting tumour-supportive cellular machineries in anticancer drug development , 2014, Nature Reviews Drug Discovery.

[26]  S. Dimmeler,et al.  EMBO Molecular Medicine: Fast Forward , 2014, EMBO molecular medicine.

[27]  S. Bicciato,et al.  Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast , 2013, EMBO molecular medicine.

[28]  T. Mak,et al.  Modulation of oxidative stress as an anticancer strategy , 2013, Nature Reviews Drug Discovery.

[29]  Zhihua Liu,et al.  Regulation of the MicroRNA 200b (miRNA-200b) by Transcriptional Regulators PEA3 and ELK-1 Protein Affects Expression of Pin1 Protein to Control Anoikis* , 2013, The Journal of Biological Chemistry.

[30]  Corbin E. Meacham,et al.  Tumour heterogeneity and cancer cell plasticity , 2013, Nature.

[31]  David A. Scott,et al.  Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.

[32]  Andrew Potter,et al.  Pin1 inhibitors: Pitfalls, progress and cellular pharmacology. , 2013, Bioorganic & medicinal chemistry letters.

[33]  H. Shih,et al.  SENP1 deSUMOylates and regulates Pin1 protein activity and cellular function. , 2013, Cancer research.

[34]  B. Posner,et al.  Identification of DNMT1 Selective Antagonists Using a Novel Scintillation Proximity Assay* , 2013, The Journal of Biological Chemistry.

[35]  M. Kuro-o,et al.  Pin1 Null Mice Exhibit Low Bone Mass and Attenuation of BMP Signaling , 2013, PloS one.

[36]  Colin J. Daniel,et al.  Pin1 Regulates the Dynamics of c-Myc DNA Binding To Facilitate Target Gene Regulation and Oncogenesis , 2013, Molecular and Cellular Biology.

[37]  Kerstin Pingel,et al.  50 Years of Image Analysis , 2012 .

[38]  F. D. D. Fagagna,et al.  Crosstalk between chromatin state and DNA damage response in cellular senescence and cancer , 2012, Nature Reviews Cancer.

[39]  R. Watson,et al.  Patented prostate cancer biomarkers , 2012, Nature Reviews Urology.

[40]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[41]  N. R. Jena.  DNA damage by reactive species: Mechanisms, mutation and repair , 2012, Journal of Biosciences.

[42]  Y. Liou,et al.  Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis , 2012, Oncogene.

[43]  Akihide Ryo,et al.  Prolyl Isomerase Pin1 Regulates Neuronal Differentiation via β-Catenin , 2012, Molecular and Cellular Biology.

[44]  K. Lu,et al.  Mixed-lineage kinase 3 phosphorylates prolyl-isomerase Pin1 to regulate its nuclear translocation and cellular function , 2012, Proceedings of the National Academy of Sciences.

[45]  L. Hedstrom,et al.  Inhibitor mediated protein degradation. , 2012, Chemistry & biology.

[46]  W. Guida,et al.  Discovery and synthesis of hydronaphthoquinones as novel proteasome inhibitors. , 2012, Journal of medicinal chemistry.

[47]  Wenjun Guo,et al.  Slug and Sox9 Cooperatively Determine the Mammary Stem Cell State , 2012, Cell.

[48]  A. Klein-Szanto,et al.  Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 , 2012, Cell Death and Differentiation.

[49]  Mishal N. Patel,et al.  Objective assessment of cancer genes for drug discovery , 2012, Nature Reviews Drug Discovery.

[50]  C. Uchida,et al.  A critical step for JNK activation: isomerization by the prolyl isomerase Pin1 , 2011, Cell Death and Differentiation.

[51]  S. Bicciato,et al.  The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells , 2011, Cell.

[52]  S. Haslam,et al.  Regulation of Estrogen Receptor α N-Terminus Conformation and Function by Peptidyl Prolyl Isomerase Pin1 , 2011, Molecular and Cellular Biology.

[53]  Clark C. Chen.  Selected Topics in DNA Repair , 2011 .

[54]  Y. Liou,et al.  Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. , 2011, Trends in biochemical sciences.

[55]  P. Chatterjee,et al.  Pin1 Deficiency Causes Endothelial Dysfunction and Hypertension , 2011, Hypertension.

[56]  Weiwei Yang,et al.  Ras-Induced and Extracellular Signal-Regulated Kinase 1 and 2 Phosphorylation-Dependent Isomerization of Protein Tyrosine Phosphatase (PTP)-PEST by PIN1 Promotes FAK Dephosphorylation by PTP-PEST , 2011, Molecular and Cellular Biology.

[57]  Antonio Rosato,et al.  A Pin1/mutant p53 axis promotes aggressiveness in breast cancer. , 2011, Cancer cell.

[58]  A. Bode,et al.  Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1 , 2011, Cancer Prevention Research.

[59]  K. Lu,et al.  Peptidyl-prolyl cis–trans isomerase Pin1 in ageing, cancer and Alzheimer disease , 2011, Expert Reviews in Molecular Medicine.

[60]  A. Goate,et al.  Death-associated protein kinase 1 phosphorylates Pin1 and inhibits its prolyl isomerase activity and cellular function. , 2011, Molecular cell.

[61]  Varda Rotter,et al.  Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. , 2011, Genes & cancer.

[62]  Adrian Whitty,et al.  The resurgence of covalent drugs , 2011, Nature Reviews Drug Discovery.

[63]  Junying Yuan,et al.  Cell death assays for drug discovery , 2011, Nature Reviews Drug Discovery.

[64]  Neal Rosen,et al.  Targeted cancer therapies , 2011, Chinese journal of cancer.

[65]  B. Davis,et al.  Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution. , 2011, Bioorganic & medicinal chemistry letters.

[66]  Xiao Zhen Zhou,et al.  The prolyl isomerase Pin1 acts as a novel molecular switch for TNF-alpha-induced priming of the NADPH oxidase in human neutrophils. , 2010, Blood.

[67]  A. Balmain,et al.  Guidelines for the welfare and use of animals in cancer research , 2010, British Journal of Cancer.

[68]  P. Khanal,et al.  The Prolyl Isomerase Pin1 Enhances HER-2 Expression and Cellular Transformation via Its Interaction with Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase 1 , 2010, Molecular Cancer Therapeutics.

[69]  N. Udupa,et al.  Juglone, a naphthoquinone from walnut, exerts cytotoxic and genotoxic effects against cultured melanoma tumor cells , 2009, Cell biology international.

[70]  T. Uchida,et al.  Dipentamethylene thiuram monosulfide is a novel inhibitor of Pin1. , 2009, Biochemical and biophysical research communications.

[71]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[72]  X. Zhou,et al.  Peptidyl-prolyl cis/trans isomerase Pin1 is critical for the regulation of PKB/Akt stability and activation phosphorylation , 2009, Oncogene.

[73]  A. Ryo,et al.  Pinning down HER2-ER crosstalk in SMRT regulation. , 2009, Trends in biochemical sciences.

[74]  Ji Luo,et al.  Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction , 2009, Cell.

[75]  Pier Paolo Di Fiore,et al.  The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer , 2009, Nature Cell Biology.

[76]  K. Lu,et al.  Prolyl Isomerase Pin 1 is Highly Expressed in Her 2-Positive Breast Cancer and Regulates erbB 2 Protein Stability , 2009 .

[77]  S. Elledge,et al.  Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction , 2009, Cell.

[78]  K. Lu,et al.  Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability , 2008, Molecular Cancer.

[79]  R. Reiter,et al.  Melatonin combats molecular terrorism at the mitochondrial level , 2008, Interdisciplinary Toxicology.

[80]  P. van der Sluijs,et al.  Juglone Inactivates Cysteine-rich Proteins Required for Progression through Mitosis* , 2008, Journal of Biological Chemistry.

[81]  M. Hung,et al.  Down-regulation of myeloid cell leukemia-1 through inhibiting Erk/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer. , 2008, Cancer research.

[82]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[83]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[84]  F. Schmidt.  Meta-Analysis , 2008 .

[85]  Charlotte Kuperwasser,et al.  Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy , 2008, Breast Cancer Research.

[86]  J. Manley,et al.  New Insights into Mitotic Chromosome Condensation: A Role for the Prolyl Isomerase Pin1 , 2007, Cell cycle.

[87]  J. Manley,et al.  Pin1 modulates RNA polymerase II activity during the transcription cycle. , 2007, Genes & development.

[88]  Xiao Zhen Zhou,et al.  The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease , 2007, Nature Reviews Molecular Cell Biology.

[89]  H. Akiyama,et al.  Ablation of a peptidyl prolyl isomerase Pin1 from p53-null mice accelerated thymic hyperplasia by increasing the level of the intracellular form of Notch1 , 2007, Oncogene.

[90]  Elisabeth S Yeh,et al.  PIN1, the cell cycle and cancer , 2007, Nature Reviews Cancer.

[91]  N. Sagata,et al.  Mechanism for inactivation of the mitotic inhibitory kinase Wee1 at M phase , 2007, Proceedings of the National Academy of Sciences.

[92]  J. Labbé,et al.  Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCFβtrcp , 2007, EMBO reports.

[93]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[94]  Y. Kwong,et al.  PIN1 expression contributes to hepatic carcinogenesis , 2006, The Journal of pathology.

[95]  L. Nicholson,et al.  The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production , 2006, Nature.

[96]  A. Ryo,et al.  Pin1 Regulates Centrosome Duplication, and Its Overexpression Induces Centrosome Amplification, Chromosome Instability, and Oncogenesis , 2006, Molecular and Cellular Biology.

[97]  G. Collins.  The next generation. , 2006, Scientific American.

[98]  K. Saxena,et al.  Polo-like Kinase 1-mediated Phosphorylation Stabilizes Pin1 by Inhibiting Its Ubiquitination in Human Cells* , 2005, Journal of Biological Chemistry.

[99]  A. Means,et al.  Peptidyl-Prolyl Isomerase 1 (Pin1) Serves as a Coactivator of Steroid Receptor by Regulating the Activity of Phosphorylated Steroid Receptor Coactivator 3 (SRC-3/AIB1) , 2005, Molecular and Cellular Biology.

[100]  F. Studier,et al.  Protein production by auto-induction in high density shaking cultures. , 2005, Protein expression and purification.

[101]  A. Means,et al.  A role for Pin1 in mammalian germ cell development and spermatogenesis. , 2004, Frontiers in bioscience : a journal and virtual library.

[102]  G. Fischer,et al.  Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases. , 2004, Frontiers in bioscience : a journal and virtual library.

[103]  Priti Garg,et al.  Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis , 2004, The EMBO journal.

[104]  J. Sowadski,et al.  Prevalent overexpression of prolyl isomerase Pin1 in human cancers. , 2004, The American journal of pathology.

[105]  Hege S. Beard,et al.  Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. , 2004, Journal of medicinal chemistry.

[106]  Matthew P. Repasky,et al.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. , 2004, Journal of medicinal chemistry.

[107]  A. Means,et al.  Spermatogonial Depletion in Adult Pin1-Deficient Mice1 , 2003, Biology of reproduction.

[108]  A. Ryo,et al.  Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. , 2003, Molecular cell.

[109]  Anna Frolov,et al.  The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. , 2003, Cancer research.

[110]  Tony Hunter,et al.  Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration , 2003, Nature.

[111]  Y. Matsuo,et al.  Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. , 2003, Chemistry & biology.

[112]  M. Ahmad,et al.  Molecular mechanisms of N-acetylcysteine actions , 2003, Cellular and Molecular Life Sciences CMLS.

[113]  S. Volinia,et al.  The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults , 2002, Nature.

[114]  Sam W. Lee,et al.  PIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells , 2002, Molecular and Cellular Biology.

[115]  J. Noel,et al.  Critical Role of WW Domain Phosphorylation in Regulating Phosphoserine Binding Activity and Pin1 Function* , 2002, The Journal of Biological Chemistry.

[116]  T. Hunter,et al.  Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[117]  Tianhua Niu,et al.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c‐Jun towards cyclin D1 , 2001, The EMBO journal.

[118]  T. Hsu,et al.  Drosophila Pin1 prolyl isomerase Dodo is a MAP kinase signal responder during oogenesis , 2001, Nature Cell Biology.

[119]  M. Kirschner,et al.  Pin1 acts catalytically to promote a conformational change in Cdc25. , 2001, Molecular cell.

[120]  Masafumi Nakamura,et al.  Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC , 2001, Nature Cell Biology.

[121]  R. Reiter.  Melatonin: Lowering the High Price of Free Radicals. , 2000, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[122]  G Fischer,et al.  Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. , 2000, Molecular cell.

[123]  C. Uchida,et al.  Mice lacking Pin1 develop normally, but are defective in entering cell cycle from G(0) arrest. , 1999, Biochemical and biophysical research communications.

[124]  G. Fischer,et al.  Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. , 1998, Biochemistry.

[125]  G. Fischer,et al.  Semiautomated microtiter plate assay for monitoring peptidylprolyl cis/trans isomerase activity in normal and pathological human sera. , 1998, Clinical chemistry.

[126]  M. Kirschner,et al.  The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. , 1998, Genes & development.

[127]  M. Kirschner,et al.  Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. , 1997, Science.

[128]  R. Ranganathan,et al.  Structural and Functional Analysis of the Mitotic Rotamase Pin1 Suggests Substrate Recognition Is Phosphorylation Dependent , 1997, Cell.

[129]  T. Hunter,et al.  A human peptidyl–prolyl isomerase essential for regulation of mitosis , 1996, Nature.

[130]  J. Kofron,et al.  Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay. , 1991, Biochemistry.

[131]  G. Fischer,et al.  [Determination of enzymatic catalysis for the cis-trans-isomerization of peptide binding in proline-containing peptides]. , 1984, Biomedica biochimica acta.

[132]  S. Shaughnessy,et al.  Do No Harm: Health Systems’ Duty to Promote Clinician Well-Being , 2022, American Journal of Hospital Medicine.